
News|Articles|December 1, 2004
Government, industry provide pharmaceutical policy outlook for 2005 and beyond
Government, industry provide pharmaceutical policy outlook for 2005; $139 million to advance information technology, records; Rofecoxib hearings point to failures in clinical testing design, decision-making transparency; New guidance for generic drugs clarifies protocol, increases speed to market
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Biosimilars in 2025: A year of firsts
2
Music and painting dual art therapy improves cognitive and social functions of hospitalized schizophrenia patients, study suggests
3
Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026
4
Low uptake of shingles vaccine despite strong value proposition for older adults
5






















































